Current treatment of small vulvar cancers

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Dermatology

Background:

• Squamous cell carcinoma of the vulva (VSCC) is a significant gynecologic malignancy.
• Approximately 50% of VSCC patients present with early-stage disease (tumors ≤2 cm).
• Early-stage VSCC (Stage I) is associated with an excellent prognosis.

Purpose of the Study:

• To review current trends in surgical management for early-stage VSCC.
• To emphasize individualized treatment strategies considering tumor and nodal status.
• To highlight the importance of analyzing risk factors for recurrence and metastasis.

Main Methods:

• Review of current surgical approaches for VSCC.
• Analysis of risk factors influencing local recurrence and groin metastasis.
• Emphasis on individualized treatment planning based on patient-specific factors.

Main Results:

• Stage I VSCC (≤2 cm tumors) demonstrates a favorable prognosis.
• There is a trend towards more conservative surgical resection of the primary tumor.
• Individualized treatment of both the primary lesion and groin lymph nodes is crucial.

Conclusions:

• Conservative surgical resection, tailored to individual risk factors, is recommended for early-stage VSCC.
• Careful analysis of local recurrence and groin metastasis risks guides treatment decisions.
• Optimizing surgical approach maximizes cure rates while minimizing morbidity.